Phenotypic predictors of response to oral glucocorticosteroids in severe asthma

Respiratory Medicine

Volumn 107, Issue 10, 2013, Pages 1521-1530

  Kupczyk, Maciej ^a,b   Haque, Shushila ^a   Middelveld, Roelinde J M ^a   Dahlén, Barbro ^a   Dahlén, Sven Erik ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Oral glucocorticosteroids; Phenotypes of asthma; Severe asthma

Indexed keywords

C REACTIVE PROTEIN; PLACEBO; PREDNISOLONE;

ADULT; AGED; ARTICLE; ASTHMA; BODY MASS; CELL COUNT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEUTROPHIL; ONSET AGE; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; SEVERE ASTHMA; SIDE EFFECT; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TREATMENT DURATION; TREATMENT RESPONSE;

ORAL GLUCOCORTICOSTEROIDS; PHENOTYPES OF ASTHMA; SEVERE ASTHMA;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ASTHMA; DOUBLE-BLIND METHOD; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PHENOTYPE; PREDNISOLONE; PROGNOSIS; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; SPUTUM; TREATMENT OUTCOME; VITAL CAPACITY; YOUNG ADULT;

EID: 84884814914     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.07.014     Document Type: Article

References (30)

1. Global Initiative for Asthma Global strategy for asthma management and prevention Available on-line at: www.ginasthma.com 2006
2. E.H. Bel, A. Sousa, L. Fleming, A. Bush, K.F. Chung, and J. Versnel Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI) Thorax 2010 Nov 23 [Epub ahead of print]
3. J. Bousquet, E. Mantzouranis, A.A. Cruz, N. Ait-Khaled, C.E. Baena-Cagnani, and E.R. Bleecker Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma J Allergy Clin Immunol 126 2010 926 938
4. W.C. Moore, E.R. Bleecker, D. Curran-Everett, S.C. Erzurum, B.T. Ameredes, and L. Bacharier Characterization of severe asthma phenotype by the National Heart, Lung and Blood Institute's Severe Asthma Research Program J Allergy Clin Immunol 119 2 2007 405 413
5. S.E. Wenzel Asthma: defining of persistent adult phenotype Lancet 368 2006 804 813
6. J. Lötvall, C.A. Akdis, L.B. Bacharier, L. Bjermer, T.B. Casale, and A. Custovic Asthma endotypes: a new approach to classification of disease entities within asthma syndrome J Allergy Clin Immunol 127 2011 355 360
7. S.J. Szefler, R.J. Martin, T.S. King, H.A. Boushey, R.M. Cherniack, and V.M. Chinchilli Significant variability in response to inhaled corticosteroids for persistent asthma J Allergy Clin Immunol 109 2002 410 418
8. E. Israel, J.M. Drazen, S.B. Liggett, H.A. Boushey, R.N. Cherniack, and V.M. Chinchilli The effect of polymorphism of the beta 2-adrenergic receptor on the response to regular use of albuterol in asthma Am J Respir Crit Care Med 162 2000 75 80
9. S.E. Dahlén, K. Malmstrom, E. Nizankowska, B. Dahlen, P. Kuna, and M. Kowalski Improvement of aspirin-intolerant asthma by montelukast a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial Am J Respir Crit Care Med 165 2002 9 14
10. K.A. Meyer, J.M. Arduino, N.C. Santanello, B.A. Knorr, and H. Bisgard Response to montelukast among subgroups of children aged 2 to 14 years with asthma J Allergy Clin Immunol 111 2003 757 762
11. M.T. Chan, D.Y. Leung, S.J. Szefler, and J.D. Spahn Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma J Allergy Clin Immunol 101 1998 594 601
12. M. Kupczyk, R. Middelveld, E.H.D. Bel, P. Chanez, and B. Dahlen The European BIOAIR trial (Longitudinal Assessment of Clinical Course and BIOmarkers in Severe Chronic AIRway Disease) - a unique data- and biobank collection to increase our understanding of severe asthma Eur Respir J 2013 in press
13. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma The ENFUMOSA Study Group Eur Respir J 22 2003 470 477
14. P.H. Quanjer, G.J. Tammeling, J.E. Cotes, O.F. Pedersen, R. Peslin, and J.C. Yernault Lung volumes and forced ventilatory flow. Report working party standardisation lung function tests, European Community for Steel and Coal. Official statement of the European Respiratory Society Eur Respir J 16 1993 5 40
15. C. Taube, B. Lehnigk, K. Paasch, D.K. Kirsten, R.A. Jörres, and H. Magnussen Factor analysis of changes in dyspnoea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 162 1 2000 216 220
16. P.L. Paggiaro, P. Chanez, O. Holz, P.W. Ind, R. Djukanovic, P. Maestrelli, and P.J. Sterk Sputum induction EurRepir J 20 Suppl. 37 2002 3s 8s
17. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Official statement by the ATS Am J Respir Crit Care Med 160 1999 2104 2117
18. P.W. Jones, F.H. Quirk, C.M. Baveystock, and P. Littlejohns A self-complete measure of health status for chronic airflow limitation. The St. George's respiratory questionnaire Am Rev Respir Dis 145 1992 1321 1327
19. E.F. Juniper, P.M. O'Byrne, G.H. Guyatt, P.J. Ferrie, and D.R. King Development and validation of a questionnaire to measure asthma control Eur Respir J 14 1999 902 907
20. C.E. Brightling, R.H. Green, and I.D. Pavord Biomarkers predicting response to corticosteroid therapy in asthma Treat Respir Med 4 2005 309 316
21. R.H. Green, C.E. Brightling, S. McKenna, B. Hargadon, D. Parker, and P. Bradding Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial Lancet 360 2002 1715 1721
22. A. ten Brinke, A.H. Zwinderman, P.J. Sterk, K.F. Rabe, and E.H. Bel "Refractory" eosinophilic airway inflammation in severe asthma Am J Respir Crit Care Med 170 2004 601 605
23. I.D. Pavord, C.E. Brightling, G. Woltmann, and A.J. Wardlaw Non-eosinophilic corticosteroid unresponsive asthma Lancet 353 1999 2213 2214
24. S.A. Little, G.W. Chalmers, K.J. MacLeod, C. McSharry, and N.C. Thomson Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma Thorax 55 2000 232 234
25. C. Lex, G. Jenkins, N.M. Wilson, A. Zacharasiewicz, E. Erin, and T.T. Hansel Does sputum eosinophilia predict the response to systemic corticosteroids in children with difficult asthma? Pediatr Pulmonol 42 2007 298 303
26. L.B. Bacharier, T.W. Guilbert, R.S. Zeiger, R.C. Strunk, W.J. Morgan, and R.F. Lemanske Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk of asthma J Allergy Clin Immunol 123 2009 1077 1082
27. I.M. Adcock, P.A. Ford, P. Bhavsar, T. Ahmad, and K.F. Chung Steroid resistance in asthma: mechanisms and treatment options Curr Allergy Asthma Rep 8 2008 171 178
28. K. Ito, K.F. Chung, and I.M. Adcock Update on glucocorticoid action and resistance J Allergy Clin Immunol 117 2006 522 543
29. P.J. Barnes Corticosteroids: the drugs to beat Eur J Pharmacol 533 2006 2 14
30. S.E. Dahlén, B. Dahlén, and J.M. Drazen Asthma treatment guidelines meet the real world N Engl J Med 364 2011 1769 1770